Canada’s Drug Agency 2024–2025 Annual Report, Shaping Change, is here. The theme this year, “Shaping Change,” aligns with our new strategic plan and reflects on a year of bringing to life our new name and enhanced role as Canada’s Drug Agency (CDA-AMC). In addition to...
MPS families carry a weight that others may never fully understand. From the moment of diagnosis, they’re asked to hold two truths simultaneously: to hope fiercely for their children while also confronting the reality that MPS can shorten their lives. It’s...
Did you know…If you’re a health care professional, you can request a drug that is not available for sale in Canada through the Special Access Program (SAP). Your request must be for treating a patient with a serious or life-threatening condition where...
Be Their Hero for a Day: Help Children with Rare Disorders Thrive! Volunteer with the Canadian MPS Society’s National Family Conference| July 18-20 | Mississauga We’re seeking compassionate volunteers to support children with Mucopolysaccharidosis...
Canadian MPS Society Annual General Meeting Date: Sunday, July 20, 2025 Time: 11:00 AM – 12:30 PM EST inclusive of Annual Report review Location: Hilton Mississauga/Meadowvale, ON The 2025 Canadian MPS Society Annual General Meeting will be held immediately...
